Inhibition of the sulfoxidation of omeprazole by ketoconazole in poor and extensive metabolizers of S-mephenytoin. (Q54597937)

1 June 2018

title

Inhibition of the sulfoxidation of omeprazole by ketoconazole in poor and extensive metabolizers of S-mephenytoin. (English)

1 reference

1 June 2018

1 reference

Böttiger Y

1

1 reference

1 June 2018

Tybring G

series ordinal

2

1 reference

1 June 2018

Götharson E

series ordinal

3

1 reference

1 June 2018

Bertilsson L

series ordinal

4

1 reference

1 June 2018

language of work or name

English

0 references

publication date

1 October 1997

1 reference

1 June 2018

Clinical Pharmacology & Therapeutics

published in

1 reference

1 June 2018

volume

62

1 reference

1 June 2018

issue

4

1 reference

1 June 2018

page(s)

384-391

1 reference

1 June 2018

Identification of human liver cytochrome P450 isoforms mediating omeprazole metabolism

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990116-8

Interaction between tolbutamide and ketoconazole in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990116-8

Slow omeprazole metabolizers are also poor S-mephenytoin hydroxylators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990116-8

Hydroxylation polymorphisms of debrisoquine and mephenytoin in European populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990116-8

Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990116-8

The effects of ketoconazole on the intestinal metabolism and bioavailability of cyclosporine*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990116-8

Oral triazolam is potentially hazardous to patients receiving systemic antimycotics ketoconazole or itraconazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990116-8

Pronounced differences between native Chinese and Swedish populations in the polymorphic hydroxylations of debrisoquin and S-mephenytoin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990116-8

Enantioselective hydroxylation of omeprazole catalyzed by CYP2C19 in Swedish white subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990116-8

Determination of ketoconazole in the plasma, liver, lung and adrenal of the rat by high-performance liquid chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990116-8

Nonlinear kinetics after high-dose omeprazole caused by saturation of genetically variable CYP2C19.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990116-8

Esophageal candidiasis, omeprazole therapy, and organ transplantation--a word of caution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990116-8

7 January 2021

Omeprazole and dry mouth

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990116-8

Polymorphic hydroxylation of S-mephenytoin and omeprazole metabolism in Caucasian and Chinese subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990116-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0009-9236(97)90116-8

1 reference

1 June 2018

1 reference

1 June 2018